KATE GRUNDY: Open Payments
NPI 1558067686 · MASHPEE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,002 in 74 payments from 19 companies in 2025. Trend: 2023 $1,687 · 2024 $2,430 · 2025 $2,002
Food & beverage: $2,002
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $500 |
| Indivior Inc. | 7 | $199 |
| ABBVIE INC. | 8 | $175 |
| Novo Nordisk Inc | 7 | $172 |
| Lilly USA, LLC | 6 | $143 |
| Janssen Pharmaceuticals, Inc | 1 | $130 |
| Verona Pharma, Inc. | 4 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $93 |
| Esperion Therapeutics, Inc. | 4 | $80 |
| Exact Sciences Corporation | 3 | $72 |
Products named: AIRSUPRA, SUBLOCADE, BREZTRI, SPRAVATO, MOUNJARO, Ohtuvayre, CAPLYTA, VRAYLAR.
Industry payments across MA — which companies pay providers there.
